More
efficient R&D and production processes are leading to increased liquid
handling automation in many laboratories. Industrial laboratories in particular
are seeking to move away from handheld pipettes towards computer-controlled
analysis systems and liquid handling equipment that makes use of robotics.
To meet the
growing demand, Biohit is now launching a
new type of tool for automated pipetting. The
Biohit Roboline is a small, quiet and
compact automated liquid handling instrument that can be placed anywhere in the
lab. Easy programmability and a fast drag-and-drop function make the tool easy
to use and suitable for a wide range of laboratory applications.
The Roboline
enables the user to simply automate a single work stage or a whole application.
The robotic dispensing module guarantees that results are accurate and precise
without the risk of human error. The instrument is particularly suitable for
low and medium-throughput laboratories
Automated
pipetting winning ground
Biohit's
core competence lies in electronic pipettes. A significant portion of
electronic pipettes used worldwide have been developed by Biohit. Biohit
Roboline is largely based on the innovations and technologies used in these
pipettes. The automatic dispenser offers a new solution to the challenges
laboratories face with regard to safety and cost-effectiveness.
The global
market for pipettes is growing about 5 to 10 per cent per year. According to
Biohit's estimates, the market for liquid handling devices will see growth in
electronic pipettes and easy-to-use desktop instruments, such as the Roboline,
in particular.
For further information please visit
www.biohit.com
About
Biohit Oyj
Biohit
Oyj is a globally operating Finnish biotechnology company that was established
in 1988. The company's mission is to improve human health and quality of life.
The company follows a goal-directed and long-term innovation and patenting
strategy.
Biohit works
with scientific communities to produce new technologies, products and services
based on research results and innovations that can be used to develop safe and
cost-effective liquid handling solutions for laboratory work as well as
diagnostic tests for the early detection and prevention of diseases of the
gastrointestinal tract.
Biohit has
two business segments: liquid handling and diagnostics. Liquid handling
products include electronic and mechanical pipettes, disposable tips as well as
pipette maintenance and calibration services for research institutions,
healthcare and industrial laboratories.
The
diagnostics business comprises products and analysis systems for the early
diagnosis and prevention of gastrointestinal diseases, such as the blood-sample
based GastroPanel examinations for the diagnosis of stomach illnesses and
associated risks, quick tests for the diagnosis of lactose intolerance and
H.
pylori infection in connection with gastroscopy, and the ColonView
examination for the early detection of intestinal bleeding that indicates a
risk of colorectal cancer. Acetium reduces the amount of carcinogenic
acetaldehyde in an anacidic stomach.
The Biohit
Group employs around 420 people. The company is headquartered in Helsinki, Finland,
and has subsidiaries in France, Germany, the UK, Russia, India, China, Japan
and the USA. The company also has a representative office in Singapore.
Biohit's products are also sold through about 200 distributors in 70 countries.
Since 1999,
Biohit's Series B share has been quoted on NASDAQ OMX Helsinki in the Small
cap/Healthcare group and is traded under the code BIOBV.